activity has a measurable and biologically significant effect on the carcinogenicity of cigarette smoke. Whether it mediates This laboratory has previously reported data suggesting a net increase or decrease in tumorigenicity is difficult to that aryl hydrocarbon receptor (AhR) signaling may have predict. However, some indirect evidence suggests that AhR a net potentiating effect on the DNA damaging potential signaling may result in a net potentiation of cigarette smoke of cigarette smoke. The experiments described in this carcinogenicity. For instance, studies have been published report extend these studies by testing whether the potent which link high aryl hydrocarbon hydroxylase inducibility (a AhR antagonist 3Ј-methoxy-4Ј-nitroflavone (3ЈM4ЈNF) can function of CYP1A activity) with increased cancer risk (6,7 wild-type mice, no tumors were observed in Ahr null allele C57Bl/6J mice; (ii) co-treatment of Ahr null allele mice with animals (9). Additional evidence is supplied by a cohort of 150 mg/kg B[a]P plus a range of 3ЈM4ЈNF concentrations in TCDD-exposed individuals (male factory workers). Increased order to evaluate the potential of the flavone to interact total cancer deaths were observed in individuals who actively with non-AhR targets which may affect B[a]P toxicity; (iii) smoked as exposure to TCDD increased. High TCDD exposure an evaluation of the in vivo AhR antagonist activity of levels were not observed to enhance total cancer deaths in 3ЈM4ЈNF using transgenic mice which carry a dioxinnon-smokers or ex-smokers (10). responsive element-regulated lacZ reporter. Once an approThe studies outlined above suggest that induction of the priate dose range was determined, C57Bl/6J mice were AhR gene battery may favor bioactivation of tobacco smoke challenged with B[a]P or CSC with and without 3ЈM4ЈNF mutagens relative to detoxification processes. Even so, it is co-treatment. Chromosome damage was measured by scorclear that no direct evidence is available which describes the ing the frequency of micronuclei in peripheral blood reticconsequence of AhR-mediated signal transduction on the ulocytes. Data presented herein suggest that 3ЈM4ЈNF can genotoxic and carcinogenic potential of cigarette smoke. For protect mice from B[a]P-induced bone marrow cytotoxicity instance, even experiments with Ahr null allele mice do and genotoxicity. Furthermore, CSC-associated genotoxicnot provide formal proof that under physiologically relevant ity was abolished by the flavonoid. These data add support circumstances AhR signaling significantly affects cigarette to our hypothesis that AhR signaling has a net potentiating smoke toxicity. Since knockout animals express a low basal effect on the genetic toxicity and, presumably, carcinolevel of CYP1A2 activity relative to controls, reduced by genicity of cigarette smoke
B[a]P. Forty-eight hours after the B[a]P bolus, spleens were collected and whether the attenuation of B[a]P genotoxicity was due to fixed with 10% neutral buffered formalin. The tissues were sectioned and inhibition of the AhR signaling pathway or CYP1A activity. stained with hematoxylin and eosin. Lesions to the spleen were quantified by
The experiments described in the current report were performed Image-Pro Plus software (v.3.0; Media Cybernetics, Silver Spring, MD).
to test whether 3ЈM4ЈNF can attenuate B[a]P-and CSCSpecifically, images of lymphocyte follicles were digitized with a Dell computer (400 MHz) and a Hitachi KP-D50 color camera attached to an induced genotoxicity at concentrations which do not significOlympus BH-2 microscope. The Image-Pro counting module was used to antly affect basal CYP1A activity. quantify pycnotic lymphocytes, i.e. those lymphocytes exhibiting condensed and deeply stained chromatin. The best scoring accuracy was obtained by adjusting the color range (red) upper threshold and the lower thresholds of
Materials and methods
the area, density and heterogeneity parameters. For each mouse four fields Reagents (four separate follicles) were analyzed. The average numbers of pycnotic cells Absolute methanol was purchased from Fisher Scientific (Springfield, NJ).
per field were compared between treatment groups by ANOVA (StatView Sodium heparin, propidium iodide (PI), RNase A, B[a]P, Triton X-100, v.4.5). P Ͻ 0.05 was considered a significant effect. phenylmethylsulfonyl fluoride, leupeptin and dithiothreitol were obtained from Dose range finding experiment: in vivo AhR antagonist activity of 3ЈM4ЈNF Sigma (St Louis, MO). 3ЈM4ЈNF was synthesized and purified (Ͼ98%) by
To investigate the ability of 3ЈM4ЈNF to antagonize the AhR in vivo, we procedures previously described (16). TCDD was purchased from Cambridge utilized male mice heterozygous for a DRE-lacZ transgene (aged 7-12 weeks). Isotopes (Cambridge, MA). Anti-CD71-FITC was purchased from BioDesign These mice express β-galactosidase (β-gal) in response to AhR agonist (clone no. R17217.1.4; Kennebunk, ME). Fixed malaria-infected mouse treatment (18). Animals were divided into four treatment groups and were erythrocytes were purchased from Litron Laboratories (Rochester, NY). CSC injected i.p. with vehicle, 15 µg/kg TCDD or 15 µg/kg TCDD plus 0.6 or was generated from University of Kentucky reference cigarettes, type 1R4F, 6 mg/kg 3ЈM4ЈNF. Note that 3ЈM4ЈNF was administered as a split dose: one as described previously (8). For injection, B[a]P, zoxazolamine and TCDD treatment 4 h prior to TCDD, a second concurrently with TCDD and a third were prepared in olive oil. CSC stock [100 mg/ml dimethyl sulfoxide (DMSO)] 4 h after TCDD (i.e. 0, 0.2 or 2 mg/kg/injection). The vehicle control group was diluted in olive oil to provide 2.5 mg/ml for injection. In early studies comprised three mice and each of the other three treatment groups comprised 3ЈM4ЈNF was prepared in DMSO. We switched to olive oil after it became four mice. Sixteen hours after TCDD exposure mice were killed by CO 2 apparent that precipitates periodically formed in the intraperitoneal cavity of asphyxiation and liver and lung sections were collected for β-gal measurements. treated mice when DMSO was the vehicle.
Specifically, tissue sections (~10ϫ10ϫ5 mm) were finely minced and transAnimals ferred to hypotonic ammonium chloride solution (ACK buffer) to lyse red Male wild-type C57Bl/6J mice were purchased from Jackson Laboratories blood cells. Minced tissue was subsequently rinsed in phosphate-buffered (Bar Harbor, ME). Male Ahr null allele mice (Ahr-/-, exon 1 targeted) were saline and transferred to 1 ml of tissue lysis solution containing 100 mM bred at SUNY (Upstate Medical University, Syracuse, NY). The founder mice potassium phosphate, pH 7.8, and 0.2% Triton X-100, supplemented with of this colony were originally developed by and received from P.Fernandezphenylmethylsulfonyl fluoride (0.2 mM), leupeptin (1 µg/ml) and dithiothreitol Salguero and F.Gonzalez (National Cancer Institute, Bethesda, MD) (17).
(1 mM) immediately before use. Tissue was homogenized between the ends Transgenic mice (DRE-lacZ) used in these studies have been described of frosted glass slides and transferred to microcentrifuge tubes. All extracts previously (18). Briefly, the DREs in this reporter are bona fide sites from were centrifuged at 12 000 g for 5 min and supernatants were held at 48°C the CYP1A1 promoter. The transgenic mice were developed by microinjecting for 60 min to inactivate endogenous β-gal (23). Samples were stored at DNA containing the DRE-lacZ construct into pronuclei of recently fertilized -20°C until analysis. Transgene-encoded bacterial β-gal activity was measured C57Bl/6JϫSJL ova. A PCR screening method was used to identify heterogzygwith a commercial luminescence assay system (Galacto Light Plus; Tropix). ous, transgene-positive mice (18) . Note that at the time of the current Activities were normalized to protein concentration (NanoOrange protein experiments the transgene-positive line had been backcrossed to the C57Bl/ quantitation kit; Molecular Probes). The effect of treatment on TCDD-induced 6J background more than nine times. Purina Mills Rodent Chow 5001 and β-gal activity was evaluated by ANOVA. P Ͻ 0.05 was considered a water were available to mice ad libitum. For all experiments mice were significant effect. allowed to acclimatize for at least 1 week.
Effect of 3ЈM4ЈNF on B[a]P and CSC genotoxicity Dose range finding experiment: zoxazolamine paralysis time
Twenty wild-type C57Bl/6J mice, age 7-8 weeks, were randomly assigned to The zoxazolamine paralysis test (19) was used to evaluate 3ЈM4ЈNF doses five treatment groups: vehicle control and B[a]P plus 0, 0.2, 2 or 20 mg/kg/ for their ability to inhibit CYP1A1/2 activity in vivo. Zoxazolamine is a potent injection 3ЈM4ЈNF. B[a]P was delivered as a bolus of 150 mg/kg i.p. and muscle relaxant which is metabolically inactivated by CYP1A1/2 enzyme 3ЈM4ЈNF was administered according to our standard split dose schedule, 4 h activity (and to a lesser extent CYP2E1). In addition to non-invasively prior to, concurrently with and 4 h after the B[a]P challenge. Fifty-four hours phenotyping mice as AhR-responsive and non-responsive (20), it has also post-B[a]P treatment peripheral blood samples were collected from the tail been used as a functional test to evaluate chemicals for their ability to inhibit vein of each mouse. Mice were killed by CO 2 overdose and spleens were CYP1A1/2 enzyme activity in vivo (21,22). Three independent experiments weighed and fixed in 10% neutral buffered formalin. Blood cells were collected were performed with male C57Bl/6J mice, 6-9 weeks old. Mice were treated and processed for flow cytometric analysis of genotoxicity as described below. with 0, 0.2, 2, 20 or 40 mg/kg 3ЈM4ЈNF i.p. Approximately 30 min after the Spleens were embedded, sectioned and stained for analysis of pycnotic 3ЈM4ЈNF injections mice were treated i.p. with zoxazolamine (125-150 mg/ lymphocytes as described. kg). Paralysis times were determined as the length of time required for mice In a second experiment, 15 wild-type C57Bl/6J mice (age 7-8 weeks) were to regain their righting reflex. Data are expressed as relative zoxazolamine divided among three treatment groups: vehicle control, CSC and CSC plus paralysis times, normalized to the average paralysis time observed for the 3ЈM4ЈNF. CSC was administered at 24 h intervals for 3 consecutive days, vehicle-treated animals in the same experiment (set at 1.0). Mean fold 25 mg/kg/injection. 3ЈM4ЈNF was administered according to the split dose induction for each 3ЈM4ЈNF exposure group was compared with the vehicle schedule described above, 4 h prior to, concurrently with and 4 h after each control group by unpaired, two-tailed t-tests (StatView v.4.5). P Ͻ 0.05 was CSC challenge. The concentration of 3ЈM4ЈNF that we chose was the lowest considered a significant effect.
in vivo concentration that was studied in the DRE-lacZ and B[a]P co-exposure models, 0.2 mg/kg/injection (i.e. 0.6 mg/kg/day). Twenty-four hours after the Dose range finding experiment: Ahr null allele mice and splenic lesions last CSC treatment peripheral blood and spleen tissues were prepared as Previous experiments have indicated that a high 3ЈM4ЈNF concentration can described above. enhance the systemic toxicity of B[a]P (14). The spleen was found to be a Genotoxicity measurements particularly sensitive target of the synergistic toxicity observed when mice were co-treated with B[a]P and 3ЈM4ЈNF. Interestingly, Ahr null allele mice
The frequency of micronuclei in peripheral blood reticulocytes was measured to index cytogenetic damage. Micronuclei arise as a consequence of clastogenic were found to exhibit the same types of splenic lesions as wild-type animals. This indicates that the synergistic toxicity observed is mediated by the ability or aneugenic action and this end-point is widely used to evaluate the carcinogenic potential of test agents (24, 25) . For the current study a high of the flavonoid to interact with a non-AhR target(s). We used this same system to evaluate the ability of the flavonoid to affect secondary (nonthroughput flow cytometric technique was used to quantify the incidence of micronuclei. Heparinized blood from each animal was fixed with ultra-cold AhR) targets.
For this experiment male Ahr-/-mice were treated i.p. with 150 mg/kg methanol and prepared for analysis as described previously (26) . Briefly, cells were collected by centrifugation and incubated in flow cytometry tubes with B[a]P. The flavonoid 3ЈM4ЈNF was administered as a split dose in an effort to maintain plasma levels. Specifically, 3ЈM4ЈNF was administered i.p. at 0, 80 µl of working RNase solution plus anti-CD71-FITC (1 mg RNase and 10 µl stock anti-CD71-FITC per ml bicarbonate-buffered saline). Cells were 0.2, 2 or 20 mg/kg/injection 4 h prior to, concurrently with and 4 h after maintained at 4°C for 30 min, moved to room temperature for 30 min and then kept on ice until analysis (the same day). Immediately before each sample was analyzed 1 ml of ice-cold PI solution was added (1.25 µg/ml PI in bicarbonate-buffered saline). Flow cytometric analysis was accomplished with a Becton Dickinson FacStar Plus tuned to provide 488 nm excitation. The FL1 detector was configured with a bandpass filter to collect emissions between 520 and 560 nm. PI-associated fluorescence was collected in the FL2 channel with a 580 long pass filter. Before scoring samples the instrument was calibrated with anti-CD71 and PI stained malaria-infected erythrocytes, which guide instrument settings including photomultiplier tube voltages and compensation values (27) . After calibration each sample was scored for reticulocyte (RET) and micronucleated reticulocyte (MN-RET) frequency upon acquisition of 20 000 total RETs (CellQuest v.3.0.1 software; Becton Dickinson). ANOVA was performed to evaluate the effect of treatment on mean RET and MN-RET frequencies. P Ͻ 0.05 was considered a significant effect.
Results

Inhibition of CYP1A activity in vivo
Initial experiments were designed to define in vivo doses of 3ЈM4ЈNF that are relatively specific for AhR antagonist activity and included a functional assay of CYP1A inhibition, the zoxazolamine paralysis test. Paralysis times, which are inversely related to CYP1A activity, are presented in Table I . previous observations that this flavonoid inhibits EROD activity in vitro (12,15) and suggest that low concentrations of 3ЈM4ЈNF have no significant effect on the basal level of marked increase in spleen lesions was found in the B[a]P plus high 3ЈM4ЈNF treatment group. On the other hand, this CYP1A1/2 enzyme activity in vivo.
toxicity was not evident at lower concentrations of flavonoid.
Ahr null allele mice and splenic lesions
Importantly, these results correlate with data obtained with In a further effort to assess 3ЈM4ЈNF for its impact on nonzoxazolamine paralysis times. While 20 mg/kg 3ЈM4ЈNF AhR targets, male Ahr null allele mice were treated with inhibits CYP1A activity, the lower concentrations of 0.2 and vehicle, 150 mg/kg B[a]P or 150 mg/kg B[a]P plus 0.2, 2 or 2 mg/kg do not result in a measurable effect. These data 20 mg/kg/injection 3ЈM4ЈNF (three injections). We utilized suggest that the splenic toxicity of B[a]P plus 3ЈM4ЈNF is a Ahr null allele mice in this experiment because they are more result of inhibition of constitutive CYP1A activity resulting in sensitive to the combined toxicity of B[a]P and 3ЈM4ЈNF (8).
either a change in deposition, clearance and/or bioactivation Furthermore, the toxicity evident in these animals would by of the procarcinogen. definition be related to non-AhR targets. After 48 h spleens
In vivo AhR antagonist activity of 3ЈM4ЈNF were collected, fixed, sectioned and stained with hematoxylin and eosin. Consistent with previous experiments (15), mice Data from the zoxazolamine and the Ahr null allele mouse experiments suggest that injections of 3ЈM4ЈNF in the range co-treated with B[a]P and 20 mg/kg/injection 3ЈM4ЈNF (three injections) exhibited small spleens with reduced red pulp. 0.2-2 mg/kg may minimally affect non-AhR target(s), and CYP1A activity in particular. To test the ability of 3ЈM4ЈNF Additionally, the incidence of pycnotic spleen lymphocytes was highly elevated (Figure 1 ). The number of pycnotic to block AhR-mediated signaling in vivo, these concentrations were evaluated in a transgenic mouse model that responds to lymphocytes per high power field were scored with ImagePro Plus software and the results are presented in Figure 2 . A AhR agonists by the induction of lacZ. Heterozygous mice were treated with 15 µg/kg TCDD and 0, 0.2 or 2 mg/kg 3ЈM4ЈNF (three injections). After 16 h liver and lung tissues were processed for β-gal measurements. These enzyme activities, normalized to protein concentration, are presented in Figure 3 . dependent reduction was observed. In fact, at a total dose of 6 mg/kg 3ЈM4ЈNF we saw a nearly complete inhibition of TCDD-induced activity. As observed in other experiments transduction on the genotoxicity of cigarette smoke mutagens. (data not shown), the liver was somewhat variable in terms of
In one experiment five male C57Bl/6J mice per group were TCDD-induced β-gal activity, and this variation is likely treated with vehicle, B[a]P alone or B[a]P plus 0.6 or 6 mg/ responsible for the lack of statistical significance in this kg 3ЈM4ЈNF (0.2 or 2 mg/kg, three injections). compartment. One possible source of variation is the relatively Observations over the 54 h treatment period suggest that at high hemoglobin content associated with the liver extracts (we the concentrations tested 3ЈM4ЈNF did not potentiate B[a]P have observed that hemoglobin interferes with chemiluminestoxicity. The animals did not exhibit any obvious signs of cence-based β-gal assays; (28) . TCDD-induced β-gal activity distress, i.e. the mice were able to maintain caloric intake, was less variable in the lung. Although 3ЈM4ЈNF was not retain their righting reflex, etc. Furthermore, spleen weight shown to reduce transgene expression to as great an extent as was not affected by B[a]P and 3ЈM4ЈNF nor was the frequency in the liver, the dose-dependent reduction was statistically of pycnotic lymphocytes enhanced (data not shown). These significant (ANOVA, P ϭ 0.046). These data directly demonresults are consistent with data from the experiment with the strate the in vivo AhR antagonist activity of the flavonoid highly sensitive Ahr null allele mice in which 20 but not 2 or 3ЈM4ЈNF in the concentration range 0.2-2 mg/kg/injection. 0.2 mg/kg/injection 3ЈM4ЈNF potentiated certain B[a]P lesions.
Effect of 3ЈM4ЈNF on B[a]P and CSC genotoxicity
Collectively, these data suggest that at the concentrations tested 3ЈM4ЈNF does not severely affect that non-AhR target(s) With a better understanding of the 3ЈM4ЈNF concentrations which are more specific for AhR antagonism compared with which is responsible for the synergistic toxicity that can result when high concentrations of 3ЈM4ЈNF are combined the one high dose that we initially studied, we were in a better position to evaluate the influence of AhR-dependent signal with B[a]P. damage. Furthermore, B[a]P-induced stem cell toxicity, as measured by reticulocyte frequency, was abolished by Discussion 3ЈM4ЈNF co-treatment. Both of these protecting effects were dose dependent and found to be statistically significant Cigarette smoke contains compounds which can transform the cytosolic AhR to an active transcription factor. However, (P Ͻ 0.05).
This experiment was followed by a study in which C57Bl/ the consequences of AhR-mediated enzyme induction on the toxicity of cigarette smoke are not clear. For instance, with 6J mice were treated with CSC with and without 3ЈM4ЈNF co-treatment. By substituting the complex mixture of chemicals regard to DNA damaging capacity it is possible that constitutive cytochrome P450 activities dictate the potency of the mixture in CSC for B[a]P we hoped to more realistically model exposure to tobacco smoke. We have previously found that a or that other biochemical processes (e.g. DNA repair) obscure any differences resulting from AhR-mediated gene transcripbolus of 25 mg/kg CSC does not induce a measurable level of DNA damage as measured by micronucleus formation, tion. Alternately, AhR-dependent events may significantly influence cigarette smoke-induced DNA damage. This informawhile a repeat dosing schedule does (data not shown). Therefore, these experiments necessarily involved repeat dosing: tion is potentially important, for it may provide the framework for identifying highly sensitive individuals and may represent CSC administered once a day for 3 days. As with previous experiments, we bracketed each CSC dose with 3ЈM4ЈNF an approach for attenuating the toxicity of similar types of exposures. injections.
The animals were closely monitored for acute signs of One of the extreme difficulties associated with the study of host and environmental factors which influence cigarette toxicity. No outward signs of distress were evident. Furthermore, spleen weights and the frequency of pycnotic lymphosmoke-induced toxicity and carcinogenicity is that exposure to tobacco smoke is so complex. Approximately 4000 chemcytes in the spleen compartment were not affected by the CSC or CSC plus 3ЈM4ЈNF treatments. Stem cell toxicity and icals are found in tobacco smoke and over 50 of these compounds are recognized as known or probable carcinogens genotoxicity data are provided in Table II . While there have been reports that high concentrations of CSC can arrest mitosis (30) . Given the multitude of bioactive compounds in smoke, it is clear that investigations hoping to supply new, mechanistic of cultured cells (29), we did not observe any change in erythropoiesis function among treatment groups, i.e. no signiinformation must employ very refined and specific methods.
In studying the influence of AhR-mediated events the availabilficant difference was observed in RET frequencies. On the other hand, the incidence of MN-RET was significantly elevated in ity of AhR mutant cells lines, DRE-reporter cells and animals and Ahr null allele mice are important and necessary tools. the CSC treatment group over the vehicle control. This low level of clastogenic activity associated with CSC was abrogated Even so, it is clear that these tools alone cannot always discriminate between the effects that agonist-induced upby the AhR antagonist 3ЈM4ЈNF.
